Navigation Links
Capitol chemistry: How Congress will alter the science landscape in 2014
Date:1/29/2014

The Congressional agenda for 2014 includes science issues with far-reaching implications for an array of issues including public health, job growth, pharmaceutical research and energy, according to an article in Chemical & Engineering News, the weekly newsmagazine of the American Chemical Society. The mid-term elections occurring this fall, however, promise to complicate progress on key legislative efforts, already stymied by a bitter partisan atmosphere.

Among the topics that the article addresses is the modernization of the Toxic Substances Control Act, a law that governs commercial chemicals. In a rare bipartisan effort, policymakers from both sides of the aisle are helping refine legislation, which was introduced last year. As it gains bipartisan momentum, private sector interests are adding friction and could affect the strength of specific provisions. Other article highlights include forecasts for energy bills to address power plant emissions and nuclear waste disposal; science policy that could encourage research and development or make it more difficult; and consumer protection laws affecting dietary supplements and antibiotics.

In addition to bills with the most obvious ties to chemical research and businesses, the article notes that industry experts also must keep a keen eye on intertwined agricultural and international issues as well. For example, the farm bill could include provisions that affect pesticide use, and trade agreements have the potential to boost domestic job growth in the chemical industries.


'/>"/>
Contact: Michael Bernstein
m_bernstein@acs.org
202-872-6042
American Chemical Society
Source:Eurekalert

Page: 1

Related biology news :

1. Stanford expert brings climate change science to heated Capitol Hill
2. Biochemistry: Unspooling DNA from nucleosomal disks
3. 7th World Congress for Rett Syndrome to convene in New Orleans, La., June 22-26
4. Purdue professor to speak before Congress about nanotechnology in brain treatment research
5. ESMO 2012 Congress: A path for medical oncology innovations
6. MARC Travel Awards announced for 2012 XXXI Congress of the Societa Italiana di Pathologia e Medicina
7. International congress on behavior, animal husbandry and animal well-being in Vienna
8. 2016 International Congress of Entomology to be held in Orlando, Florida
9. Madidi conservationist wins award at World Conservation Congress
10. Noteworthy studies at the ESMO 2012 Congress
11. Majority of Americans doubt Congress and White House can avoid fiscal cliff
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/18/2018)... (PRWEB) , ... December 18, 2018 , ... ... developing non-invasive treatments for cancers and other serious diseases, today announced the publication ... device is safe for treatment of rGBM. , The publication of the ...
(Date:12/13/2018)... ... ... Study Protocol Summary of QC Procedure , 1 – Patient Enrolment (with ... the site., 3 - Three photos captured with Apple iPad and transferred to each ... Photos moved to eAdjudication® and submitted to Reviewers., 6 - Reviewers (blinded) repeats ...
(Date:12/13/2018)... ... December 12, 2018 , ... Illumina, Kaiser Permanente, ResMed and Aetna were just ... Diego-based team-building and cooking events company has hosted an impressive guest list of Fortune ... , Each group who visits receives a completely customized experience, right down to ...
Breaking Biology News(10 mins):
(Date:1/10/2019)... ... January 08, 2019 , ... ... an innovative spinal implant company, announced today that SAGICO will be represented ... The annual J.P. Morgan Healthcare Conference is the largest and most ...
(Date:1/8/2019)... ... January 07, 2019 , ... Today ... Noninvasix. This represents the second investment AngelMD has made into Noninvasix in the ... is developing a patient monitor to directly, accurately, and noninvasively measure brain oxygenation ...
(Date:1/7/2019)... ... January 07, 2019 , ... Kainos Medicine ... Parkinson's Disease drug candidate, code-named "KM-819." KM-819 is an orally active small ... place in South Korea. , This Phase 1 randomized, double-blind, placebo-controlled dose-escalation ...
(Date:1/4/2019)... ... January 01, 2019 , ... ... at the World Economic Forum Annual Meeting January 22-25, 2019 held in Davos-Klosters, ... , The World Economic Forum Annual Meeting brings together leaders of global society–the ...
Breaking Biology Technology: